JP2019517540A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019517540A5 JP2019517540A5 JP2018563815A JP2018563815A JP2019517540A5 JP 2019517540 A5 JP2019517540 A5 JP 2019517540A5 JP 2018563815 A JP2018563815 A JP 2018563815A JP 2018563815 A JP2018563815 A JP 2018563815A JP 2019517540 A5 JP2019517540 A5 JP 2019517540A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- composition
- antibody
- administered
- body weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022129326A JP2022145965A (ja) | 2016-06-07 | 2022-08-15 | アルツハイマー病を治療する方法 |
| JP2025124966A JP2025160337A (ja) | 2016-06-07 | 2025-07-25 | アルツハイマー病を治療する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662346818P | 2016-06-07 | 2016-06-07 | |
| US62/346,818 | 2016-06-07 | ||
| US201662435531P | 2016-12-16 | 2016-12-16 | |
| US62/435,531 | 2016-12-16 | ||
| PCT/EP2017/063711 WO2017211827A1 (en) | 2016-06-07 | 2017-06-06 | Methods for treating alzheimer's disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022129326A Division JP2022145965A (ja) | 2016-06-07 | 2022-08-15 | アルツハイマー病を治療する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019517540A JP2019517540A (ja) | 2019-06-24 |
| JP2019517540A5 true JP2019517540A5 (https=) | 2020-07-09 |
Family
ID=59067640
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018563815A Withdrawn JP2019517540A (ja) | 2016-06-07 | 2017-06-06 | アルツハイマー病を治療する方法 |
| JP2022129326A Withdrawn JP2022145965A (ja) | 2016-06-07 | 2022-08-15 | アルツハイマー病を治療する方法 |
| JP2025124966A Pending JP2025160337A (ja) | 2016-06-07 | 2025-07-25 | アルツハイマー病を治療する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022129326A Withdrawn JP2022145965A (ja) | 2016-06-07 | 2022-08-15 | アルツハイマー病を治療する方法 |
| JP2025124966A Pending JP2025160337A (ja) | 2016-06-07 | 2025-07-25 | アルツハイマー病を治療する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20200308259A1 (https=) |
| EP (1) | EP3464350A1 (https=) |
| JP (3) | JP2019517540A (https=) |
| KR (2) | KR20190021311A (https=) |
| CN (3) | CN114796481A (https=) |
| AU (2) | AU2017276656A1 (https=) |
| BR (1) | BR112018075300A2 (https=) |
| CA (1) | CA3026598A1 (https=) |
| IL (1) | IL263433B2 (https=) |
| MA (1) | MA45149A (https=) |
| MX (1) | MX2018015022A (https=) |
| WO (1) | WO2017211827A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201827467A (zh) | 2016-11-03 | 2018-08-01 | 比利時商健生藥品公司 | 焦穀胺酸類澱粉蛋白－β之抗體及其用途 |
| EP3696192A1 (en) | 2019-02-15 | 2020-08-19 | Consejo Superior De Investigaciones Científicas | Therapeutic target and monoclonal antibodies against it for the diagnosis and treatment of alzheimer´s disease |
| US20220177560A1 (en) | 2019-03-26 | 2022-06-09 | Janssen Pharmaceutica Nv | Antibodies to Pyroglutamate Amyloid-B and Uses Thereof |
| CN110511276A (zh) * | 2019-08-13 | 2019-11-29 | 王跃驹 | 植物作为宿主在表达Aducanumab抗体中的应用 |
| MX2022004678A (es) * | 2019-10-22 | 2022-08-15 | Biogen Ma Inc | Anticuerpo anti-beta amiloide para el tratamiento de la enfermedad de alzheimer. |
| MX2023000949A (es) | 2020-07-23 | 2023-02-22 | Othair Prothena Ltd | Anticuerpos anti-beta-amiloide (abeta). |
| KR102321601B1 (ko) * | 2020-11-19 | 2021-11-05 | 주식회사 휴런 | 뇌 영상을 이용한 알츠하이머병의 생물학적 분류 장치 및 방법 |
| WO2022261026A2 (en) * | 2021-06-07 | 2022-12-15 | Biogen Ma Inc. | Methods for treating alzheimer's disease |
| US20250122146A1 (en) * | 2021-09-30 | 2025-04-17 | The Scripps Research Institute | Compounds for reducing neuroinflammation |
| MX2024005999A (es) * | 2021-11-19 | 2024-05-30 | Ap Biosciences Inc | Anticuerpos bispecificos dirigidos a cd137 y usos de los mismos para la inmunoterapia anticancer. |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2468770T (lt) * | 2006-07-14 | 2018-05-25 | Ac Immune S.A. | Humanizuotas antikūnas prieš beta amiloidą |
| KR20120017469A (ko) | 2007-01-05 | 2012-02-28 | 유니버시티 오브 취리히 | 질환 특이적 결합 분자 및 표적을 제공하는 방법 |
| BR112013008765B8 (pt) | 2010-10-11 | 2023-05-02 | Biogen Idec Int Neuroscience Gmbh | Anticorpos monoclonais anti-tau humano isolados ou um fragmento de ligação à tau dos mesmos, métodos de preparação dos mesmos, polinucleotídeo ou polinucleotídeos, vetor ou vetores, composição, método in vitro de diagnóstico ou monitoramento da progressão de uma tauopatia neurodegenerativa em um indivíduo humano, método in vitro para diagnosticar uma tauopatia neurodegenerativa em um indivíduo humano, e kit útil para o diagnóstico de uma tauopatia neurodegenerativa |
| RU2689674C2 (ru) * | 2012-10-15 | 2019-05-28 | Медиммьюн Лимитед | Антитела к бета-амилоиду |
| CN105979962A (zh) * | 2012-12-07 | 2016-09-28 | 比奥根国际神经科学公司 | 使用抗Aβ抗体减少脑淀粉样蛋白斑块的方法 |
| PT2935326T (pt) | 2012-12-21 | 2020-09-14 | Biogen Ma Inc | Anticorpos anti-tau humanos |
| RU2724190C2 (ru) * | 2014-02-08 | 2020-06-23 | Дженентек, Инк. | Способы лечения болезни альцгеймера |
| MA41115A (fr) * | 2014-12-02 | 2017-10-10 | Biogen Int Neuroscience Gmbh | Procédé de traitement de la maladie d'alzheimer |
-
2017
- 2017-06-06 CA CA3026598A patent/CA3026598A1/en active Pending
- 2017-06-06 MA MA045149A patent/MA45149A/fr unknown
- 2017-06-06 KR KR1020197000443A patent/KR20190021311A/ko not_active Ceased
- 2017-06-06 AU AU2017276656A patent/AU2017276656A1/en not_active Abandoned
- 2017-06-06 CN CN202210397569.0A patent/CN114796481A/zh active Pending
- 2017-06-06 CN CN201780044190.9A patent/CN109476730A/zh active Pending
- 2017-06-06 WO PCT/EP2017/063711 patent/WO2017211827A1/en not_active Ceased
- 2017-06-06 MX MX2018015022A patent/MX2018015022A/es unknown
- 2017-06-06 EP EP17730427.6A patent/EP3464350A1/en active Pending
- 2017-06-06 BR BR112018075300-9A patent/BR112018075300A2/pt unknown
- 2017-06-06 JP JP2018563815A patent/JP2019517540A/ja not_active Withdrawn
- 2017-06-06 US US16/307,364 patent/US20200308259A1/en not_active Abandoned
- 2017-06-06 CN CN202210397435.9A patent/CN114931635A/zh active Pending
- 2017-06-06 KR KR1020237040938A patent/KR20230165883A/ko not_active Ceased
- 2017-06-06 IL IL263433A patent/IL263433B2/en unknown
-
2022
- 2022-02-25 US US17/681,011 patent/US20220281963A1/en not_active Abandoned
- 2022-08-15 JP JP2022129326A patent/JP2022145965A/ja not_active Withdrawn
-
2024
- 2024-08-29 AU AU2024216442A patent/AU2024216442A1/en active Pending
-
2025
- 2025-07-25 JP JP2025124966A patent/JP2025160337A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019517540A5 (https=) | ||
| TWI306458B (en) | Humanized antibodies that recognize beta amyloid peptide | |
| TWI890481B (zh) | 雙特異性抗體 | |
| JP2020141669A5 (https=) | ||
| JP2020512368A5 (https=) | ||
| JP2020503260A5 (https=) | ||
| JP2017511793A5 (https=) | ||
| JP2018519810A5 (https=) | ||
| CA2478049A1 (en) | Humanized antibodies that recognize beta amyloid peptide | |
| JP2019521647A5 (https=) | ||
| JP2017536414A5 (https=) | ||
| JP2015514110A5 (https=) | ||
| JP2018500014A5 (https=) | ||
| HRP20231134T1 (hr) | Humanizirana i afinitetno zrela protutijela na fcrh5 i postupci za uporabu | |
| CN114173816A (zh) | 通过施用il-4r拮抗剂治疗特应性皮炎的方法 | |
| RU2017102514A (ru) | Гуманизированные анти-тау-антитела | |
| JP2022145965A (ja) | アルツハイマー病を治療する方法 | |
| JP2017534646A5 (https=) | ||
| RU2017120358A (ru) | Анти-il-1-бета антитела и способы их применения | |
| JP2019513726A5 (https=) | ||
| JP2018529661A5 (https=) | ||
| JP2021502349A5 (https=) | ||
| JP2019532970A5 (https=) | ||
| JP2018526330A5 (https=) | ||
| JP2018535961A5 (https=) |